Analyst Price Targets — ADUS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 25, 2026 1:53 pm | Ben Hendrix | RBC Capital | $139.00 | $103.08 | StreetInsider | RBC Capital on Addus HomeCare (ADUS): 'Post-4Q pull-back unwarranted' |
| February 24, 2026 10:21 am | — | Barclays | $112.00 | $117.63 | TheFly | Addus HomeCare price target lowered to $112 from $117 at Barclays |
| January 7, 2026 12:06 pm | Clarke Murphy | Truist Financial | $135.00 | $110.98 | TheFly | Addus HomeCare initiated with a Buy at Truist |
| November 4, 2025 10:07 am | Andrew Mok | Barclays | $117.00 | $118.99 | TheFly | Addus HomeCare price target raised to $117 from $111 at Barclays |
| September 2, 2025 9:10 am | — | UBS | $145.00 | $115.67 | TheFly | Addus HomeCare initiated with a Buy at UBS |
| December 16, 2024 9:50 am | Constantine Davides | JMP Securities | $150.00 | $122.96 | TheFly | Addus HomeCare initiated with an Outperform at JMP Securities |
| November 6, 2024 11:27 am | Scott Fidel | Stephens | $145.00 | $124.68 | StreetInsider | Addus HomeCare (ADUS) PT Raised to $145 at Stephens |
| October 10, 2024 5:49 pm | Matthew Gillmor | KeyBanc | $150.00 | $127.44 | TheFly | Addus HomeCare initiated with an Overweight at KeyBanc |
| September 23, 2024 7:29 am | Michael Wiederhorn | Oppenheimer | $145.00 | $131.35 | StreetInsider | Addus HomeCare (ADUS) PT Raised to $145 at Oppenheimer |
| August 8, 2024 6:18 am | Frank Morgan | RBC Capital | $141.00 | $122.22 | StreetInsider | Addus HomeCare (ADUS) PT Raised to $141 at RBC Capital |
Latest News for ADUS
Addus HomeCare (NASDAQ: ADUS - Get Free Report) and Daxor (NASDAQ: DXR - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, institutional ownership, analyst recommendations and profitability. Volatility and Risk Addus HomeCare has a beta
Addus HomeCare Corporation (ADUS) Q4 2025 Earnings Call Transcript
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that management will participate in the Raymond James & Associates 47th Annual Institutional Investors Conference, which takes place March 1 – 4, 2026, in Orlando, Florida. In connection with the conference, there will be a live broadcast and replay of the Company's presentation available…
Although the revenue and EPS for Addus HomeCare (ADUS) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Addus HomeCare (ADUS) came out with quarterly earnings of $1.77 per share, beating the Zacks Consensus Estimate of $1.71 per share. This compares to earnings of $1.38 per share a year ago.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ADUS.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.